Search

• Written by: D.A. Fennell ×
• Person: J. Trigo ×
• Clear filters

1 result for “Reaction Department”

1. Medical study · Medical research · 2020

   A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma

   …mg/kg and used for cohort expansion. The most common treatment-related adverse events (AEs) were nausea (56%), decreased appetite (36%), infusion reactions (36%), decreased neutrophil counts (36%), and fatigue (33%). The confirmed ORR was 39%…